3,3',5-triiodothyroacetic acid has been researched along with Obesity in 13 studies
tiratricol : A monocarboxylic acid that is (4-hydroxy-3,5-diiodophenyl)acetic acid in which the phenolic hydroxy group has been replaced by a 4-hydroxy-3-iodophenoxy group. It is a thyroid hormone analogue that has been used in the treatment of thyroid hormone resistance syndrome.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "3,5-Dimethyl-3'-isopropyl-L-thyronine (DIMIT) and 3,5-diiodo-3'-isopropylthyroacetic acid (IpTA2), two thyroid hormone analogs, have been tested in genetically obese Zucker rats and their lean littermates, in comparison with thyroxine (T4) and triiodothyronine (T3) for their thyromimetic activities on body weight gain and lipid levels in serum and liver." | 7.67 | Comparative effects of 3,5-dimethyl-3'-isopropyl-L-thyronine (DIMIT) and 3,5-diiodo-3'-isopropylthyroacetic acid (IpTA2) on body weight gain and lipid metabolism in genetically obese Zucker rats. ( Autissier, N; Dumas, P; Jorgensen, EC; Loireau, A; Michel, O; Michel, R, 1986) |
| "3,5-Dimethyl-3'-isopropyl-L-thyronine (DIMIT) and 3,5-diiodo-3'-isopropylthyroacetic acid (IpTA2), two thyroid hormone analogs, have been tested in genetically obese Zucker rats and their lean littermates, in comparison with thyroxine (T4) and triiodothyronine (T3) for their thyromimetic activities on body weight gain and lipid levels in serum and liver." | 3.67 | Comparative effects of 3,5-dimethyl-3'-isopropyl-L-thyronine (DIMIT) and 3,5-diiodo-3'-isopropylthyroacetic acid (IpTA2) on body weight gain and lipid metabolism in genetically obese Zucker rats. ( Autissier, N; Dumas, P; Jorgensen, EC; Loireau, A; Michel, O; Michel, R, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (69.23) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danilovic, DL | 1 |
| Bloise, W | 1 |
| Knobel, M | 1 |
| Marui, S | 1 |
| BANSI, HW | 1 |
| OLSEN, JM | 1 |
| Dumas, P | 3 |
| Autissier, N | 3 |
| Loireau, A | 3 |
| Michel, R | 3 |
| Bentin, J | 1 |
| Désir, D | 1 |
| Mockel, J | 1 |
| Heim, J | 1 |
| Chow, WS | 1 |
| Lam, KS | 1 |
| Devoto, E | 1 |
| Aravena, L | 1 |
| Arnal, J | 1 |
| Bourquin, C | 1 |
| Pluvinage, R | 1 |
| Chicouri, M | 1 |
| Lledo Carreres, M | 1 |
| Lajo Garrido, JL | 1 |
| Gonzalez Rico, M | 1 |
| Navarro Polo, JN | 1 |
| Escobar Cava, P | 1 |
| Aznar Saliente, T | 1 |
| Beck-Peccoz, P | 1 |
| Sartorio, A | 1 |
| De Medici, C | 1 |
| Grugni, G | 1 |
| Morabito, F | 1 |
| Faglia, G | 1 |
| Michel, O | 1 |
| Jorgensen, EC | 1 |
13 other studies available for 3,3',5-triiodothyroacetic acid and Obesity
| Article | Year |
|---|---|
Factitious thyrotoxicosis induced by mesotherapy: a case report.
Topics: Adipose Tissue; Adult; Cosmetic Techniques; Female; Humans; Obesity; Thyrotoxicosis; Triiodothyronin | 2008 |
[The hormone effects of triiodothyroacetic acid studies in adipose and myxedematous patients].
Topics: Adiposity; Hormones; Humans; Myxedema; Obesity; Research; Triiodothyronine | 1959 |
[Effects of 3,5,3'-triiodothyroacetic acid (TRIAC) on protein metabolism of genetically obese or non-obese Zucker rats].
Topics: Animals; Brain; Carbon Radioisotopes; Female; Kidney; Leucine; Liver; Muscles; Myocardium; Obesity; | 1982 |
Triac (3,5,3'-triiodo-thyroacetic acid) induced "pseudohypothyroidism".
Topics: Adult; Female; Humans; Hypothyroidism; Obesity; Thyroid Hormones; Thyrotropin; Triiodothyronine | 1984 |
[Hypothyroidism of central origin corrected by the cessation of Triac therapy].
Topics: Female; Humans; Hypothalamo-Hypophyseal System; Hypothyroidism; Middle Aged; Obesity; Thyroid Hormon | 1982 |
Thyroid status and effects of 3,5,3' triiodothyroacetic acid and fenproporex in genetically lean and obese female rats.
Topics: Amphetamines; Animals; Appetite Depressants; Body Weight; Eating; Female; Lipids; Obesity; Rats; Thy | 1980 |
An overweight woman with galactorrhoea.
Topics: Adult; Female; Galactorrhea; Humans; Hyperprolactinemia; Obesity; Self Medication; Triiodothyronine | 1998 |
[Adverse effect of 3,5,3 triiodothyroacetic acid in the treatment of obesity].
Topics: Adult; Humans; Middle Aged; Obesity; Thyroid Function Tests; Thyrotropin; Triiodothyronine | 2001 |
[Treatment of obesity. Current data on TRIAC].
Topics: Humans; Obesity; Triiodothyronine | 1976 |
[Overweight and thymo-affective disorders. Results of treatment with Triac].
Topics: Adult; Affective Symptoms; Aged; Drug Evaluation; Female; Humans; Male; Middle Aged; Obesity; Triiod | 1975 |
Toxic internuclear ophthalmoplegia related to antiobesity treatment.
Topics: Adult; Diplopia; Female; Fenfluramine; Humans; Obesity; Ophthalmoplegia; Triiodothyronine | 1992 |
Dissociated thyromimetic effects of 3, 5, 3'-triiodothyroacetic acid (TRIAC) at the pituitary and peripheral tissue levels.
Topics: Adult; Body Weight; Double-Blind Method; Female; Heart Rate; Humans; Lipids; Obesity; Random Allocat | 1988 |
Comparative effects of 3,5-dimethyl-3'-isopropyl-L-thyronine (DIMIT) and 3,5-diiodo-3'-isopropylthyroacetic acid (IpTA2) on body weight gain and lipid metabolism in genetically obese Zucker rats.
Topics: Animals; Body Weight; DNA-Directed RNA Polymerases; Female; Lipid Metabolism; Liver; Obesity; Rats; | 1986 |